BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21098276)

  • 1. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
    Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.
    Mortier E; Woo T; Advincula R; Gozalo S; Ma A
    J Exp Med; 2008 May; 205(5):1213-25. PubMed ID: 18458113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
    Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
    Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.
    Zhang M; Ju W; Yao Z; Yu P; Wei BR; Simpson RM; Waitz R; Fassò M; Allison JP; Waldmann TA
    J Immunol; 2012 Jun; 188(12):6156-64. PubMed ID: 22593619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.
    Tamzalit F; Barbieux I; Plet A; Heim J; Nedellec S; Morisseau S; Jacques Y; Mortier E
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8565-70. PubMed ID: 24912180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
    Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
    J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
    Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
    J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells.
    Robinson TO; Hegde SM; Chang A; Gangadharan A; Rivas S; Madakamutil L; Zalevsky J; Miyazaki T; Schluns KS
    J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34375310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.
    Viaud S; Terme M; Flament C; Taieb J; André F; Novault S; Escudier B; Robert C; Caillat-Zucman S; Tursz T; Zitvogel L; Chaput N
    PLoS One; 2009; 4(3):e4942. PubMed ID: 19319200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.
    Finch DK; Stolberg VR; Ferguson J; Alikaj H; Kady MR; Richmond BW; Polosukhin VV; Blackwell TS; McCloskey L; Curtis JL; Freeman CM
    Am J Respir Crit Care Med; 2018 Nov; 198(9):1140-1150. PubMed ID: 29676596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
    Rowley J; Monie A; Hung CF; Wu TC
    J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
    Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15/IL-15Rα treatment.
    Nair S; Fang M; Sigal LJ
    Aging Cell; 2015 Apr; 14(2):180-90. PubMed ID: 25399821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different NK cell developmental events require different levels of IL-15 trans-presentation.
    Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
    J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Anton OM; Peterson ME; Hollander MJ; Dorward DW; Arora G; Traba J; Rajagopalan S; Snapp EL; Garcia KC; Waldmann TA; Long EO
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):522-531. PubMed ID: 31871169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
    Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
    J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.
    Koka R; Burkett P; Chien M; Chai S; Boone DL; Ma A
    J Immunol; 2004 Sep; 173(6):3594-8. PubMed ID: 15356102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.